Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
1999-8-26
pubmed:databankReference
pubmed:abstractText
The drug brefeldin A (BFA) disrupts protein traffic and Golgi morphology by blocking activation of ADP ribosylation factors (ARFs) through an unknown mechanism. Here, we investigated the cellular localization and BFA sensitivity of human p200 ARF-GEP1 (p200), a ubiquitously expressed guanine nucleotide exchange factor of the Sec7 domain family. Multiple tagged forms of the full-length polypeptide localized to tight ribbon-like perinuclear structures that overlapped with the Golgi marker mannosidase II and were distinct from the pattern observed with ERGIC53/58. Analysis of several truncated forms mapped the Golgi-localization signal to the N-terminal third of p200. BFA treatment of transiently or stably transfected cells resulted in the redistribution of Golgi markers and in loss of cell viability, thereby indicating that overproduction of p200 may not be sufficient to overcome the toxic effect. A 39-kDa fragment spanning the Sec7 domain catalyzed loading of guanosine 5'-[gamma-thio]triphosphate onto class I ARFs and displayed clear sensitivity to BFA. Kinetic analysis established that BFA did not compete with ARF for interaction with p200 but, rather, acted as an uncompetitive inhibitor that only targeted the p200-ARF complex with an inhibition constant of 7 microM. On the basis of these results, we propose that accumulation of an abortive p200-ARF complex in the presence of BFA likely leads to disruption of Golgi morphology. p200 mapped to chromosome 8q13, 3.56 centirays from WI-6151, and database searches revealed the presence of putative isoforms whose inhibition may account for the effects of BFA on various organelles.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-1448151, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-1448152, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-1740466, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-2004424, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-3042778, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-7744796, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-8027187, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-8325164, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-8486645, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-8917509, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-8945477, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-8945478, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9288971, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9371777, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9417041, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9539714, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9649435, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9707577, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9714733, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9784132, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9788883, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9790530, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9802902, http://linkedlifedata.com/resource/pubmed/commentcorrection/10393931-9828135
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
6
pubmed:volume
96
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7968-73
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:10393931-Amino Acid Sequence, pubmed-meshheading:10393931-Animals, pubmed-meshheading:10393931-Base Sequence, pubmed-meshheading:10393931-Brefeldin A, pubmed-meshheading:10393931-Cell Line, pubmed-meshheading:10393931-Cell Survival, pubmed-meshheading:10393931-Cricetinae, pubmed-meshheading:10393931-DNA Primers, pubmed-meshheading:10393931-Fungal Proteins, pubmed-meshheading:10393931-Golgi Apparatus, pubmed-meshheading:10393931-Guanine Nucleotide Exchange Factors, pubmed-meshheading:10393931-Humans, pubmed-meshheading:10393931-Male, pubmed-meshheading:10393931-Molecular Sequence Data, pubmed-meshheading:10393931-Polymerase Chain Reaction, pubmed-meshheading:10393931-Proteins, pubmed-meshheading:10393931-Recombinant Proteins, pubmed-meshheading:10393931-Saccharomyces cerevisiae, pubmed-meshheading:10393931-Sequence Alignment, pubmed-meshheading:10393931-Sequence Homology, Amino Acid, pubmed-meshheading:10393931-Testis, pubmed-meshheading:10393931-Transfection
pubmed:year
1999
pubmed:articleTitle
p200 ARF-GEP1: a Golgi-localized guanine nucleotide exchange protein whose Sec7 domain is targeted by the drug brefeldin A.
pubmed:affiliation
Department of Cell Biology, University of Alberta, MSB 5-14, Edmonton, AB T6G 2H7, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't